Clinical Trial Update: A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2a clinical trial of Budoprutug for immune thrombocytopenia is currently recruiting, sponsored by Climb Bio, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Budoprutug (Budoprutug)

Snippet

Sponsor: Climb Bio, Inc. | Conditions: Immune Thrombocytopenia (ITP), ITP | Phase 1, Phase 2 | Status: RECRUITING